Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 3219, Suchdauer: 0.76s

12 3 4 5 6 7 8 9 10 11 weiter »

1
Delving into tRNA-derived small RNAs in multiple myeloma: elevated 3′U-tRFSerTGA leads to poor disease prognosis

von Soureas, Konstantinos ; Malandrakis, Panagiotis ; Papadimitriou, Maria-Alexandra ; et al.

British Journal of Cancer. :1-10
- Zum Volltext (via ReDI)
Merkliste

2
The impact of high-risk cytogenetics on treatment efficacy and outcomes of patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis of randomized controlled trials

von Ntanasis-Stathopoulos, Ioannis ; Filippatos, Charalampos ; Malandrakis, Panagiotis ; et al.

Leukemia. 39(9):2226-2236
- Zum Volltext (via ReDI)
Merkliste

3
SOHO State of the Art Updates and Next Questions | Monoclonal Gammopathy of Clinical Significance: A Multisystem Disorder Requiring a Multidisciplinary Approach

von Dimopoulos, Meletios Athanasios ; Theodorakakou, Foteini ; Kastritis, Efstathios

In Clinical Lymphoma, Myeloma and Leukemia July 2026 26(7):e953-e968
- View full text via DOI
Merkliste

4
BRIDGE (OP-107): A Phase 2 Pharmacokinetic Study of Melflufen Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and Impaired Renal Function

von Pour, Ludek ; Delimpasi, Sosana ; Legiec, Wojciech ; et al.

In Clinical Lymphoma, Myeloma and Leukemia July 2026 26(7):e942-e952
- View full text via DOI
Merkliste

5
Correction: The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development

von Mukhopadhyay, Pralay ; Abdullah, Hesham A. ; Opalinska, Joanna B. ; et al.

Blood Cancer Journal. 15(1)
- Zum Volltext in PubMed Central
Merkliste

6
Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome

von Soureas, Konstantinos ; Malandrakis, Panagiotis ; Papadimitriou, Maria-Alexandra ; et al.

Blood Cancer Journal. 15(1)
- Zum Volltext in PubMed Central
Merkliste

7
Circulating tumor cells by Next Generation Flow Cytometry as a new prognostic biomarker for patients with asymptomatic monoclonal gammopathies

von Kastritis, Efstathios ; Malandrakis, Panagiotis ; Kostopoulos, Ioannis V. ; et al.

Blood Cancer Journal. 15(1)
- Zum Volltext in PubMed Central
Merkliste

8
The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development

von Mukhopadhyay, Pralay ; Abdullah, Hesham A. ; Opalinska, Joanna B. ; et al.

Blood Cancer Journal. 15(1)
- Zum Volltext in PubMed Central
Merkliste

9
SOHO State of the Art Updates and Next Questions | Treatment of Myeloma Early Relapse: Non-CAR T Cell

von Gavriatopoulou, Maria ; Manganas, Sotirios ; Ntanasis-Stathopoulos, Ioannis ; et al.

In Clinical Lymphoma, Myeloma and Leukemia February 2026 26(2):66-72
- View full text via DOI
Merkliste

10
Observation or treatment for smoldering multiple myeloma? A systematic review and meta-analysis of randomized controlled studies

von Ntanasis-Stathopoulos, Ioannis ; Filippatos, Charalampos ; Malandrakis, Panagiotis ; et al.

Blood Cancer Journal. 15(1)
- Zum Volltext in PubMed Central
Merkliste

11
Cardiovascular Safety of Carfilzomib in Patients with Multiple Myeloma

von Tentolouris, Anastasios ; Ntanasis-Stathopoulos, Ioannis ; Filippatos, Charalampos ; et al.

In Clinical Lymphoma, Myeloma and Leukemia February 2026 26(2):e172-e179
- View full text via DOI
Merkliste

12
Genomic landscape of multiple myeloma and its precursor conditions

von Alberge, Jean-Baptiste ; Dutta, Ankit K. ; Poletti, Andrea ; et al.

Nature Genetics. 57(6):1493-1503
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

13
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial

von Tsirigotis, Panagiotis ; Pereira, Juliana ; Gonzalez de Villambrosia, Sonia ; et al.

In The Lancet 10-16 January 2026 407(10524):161-173
- View full text via DOI
Merkliste

14
Improvement in Cardiac Magnetic Resonance Parameters in Patients With Cardiac Light-Chain Amyloidosis Receiving Anticlonal Cell Therapy

von Briasoulis, Alexandros ; Lama, Niki ; Soranidis, Angelos ; et al.

In Clinical Lymphoma, Myeloma and Leukemia January 2026
- View full text via DOI
Merkliste

15
Immunotherapy in primary hormone-receptor positive breast cancer: A systematic review

von Melissari, Maria-Theodora ; Papatheodoridi, Alkistis ; Argyriadis, Athanasios ; et al.

In Critical Reviews in Oncology / Hematology August 2025 212
- View full text via DOI
Merkliste

16
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial

von Falchi, Lorenzo ; Nijland, Marcel ; Huang, Huiqiang ; et al.
- View full text via BASE
Merkliste

17
Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatin

von Efentakis, Panagiotis ; Choustoulaki, Angeliki ; Kwiatkowski, Grzegorz ; et al.

Basic Research in Cardiology. 120(1):263-286
- Zum Volltext (via ReDI)
Merkliste

18
Evaluation of Clinical Characteristics and Prognostic Factors of Early Progressive Disease (EPD) in Newly Diagnosed Multiple Myeloma Patients: Real-World Data of the Greek Myeloma Study Group

von Katodritou, Eirini ; Kastritis, Efstathios ; Dalampira, Dimitra ; et al.

In Clinical Lymphoma, Myeloma and Leukemia June 2025 25(6):e359-e365
- View full text via DOI
Merkliste

19
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

20
PARP inhibitors during conception and pregnancy in breast cancer

von Zagouri, Flora ; Dimopoulos, Meletios-Athanasios ; Andrikopoulou, Angeliki

In Critical Reviews in Oncology / Hematology June 2025 210
- View full text via DOI
Merkliste

21
Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma

von Kumar, Shaji ; Jagannath, Sundar ; Weisel, Katja C. ; et al.

Blood Cancer Journal. 16(1)
- Zum Volltext in PubMed Central
Merkliste

22
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

23
Sustained bone marrow and imaging MRD negativity for 3 years drives discontinuation of maintenance post-ASCT in myeloma

von Terpos, Evangelos ; Malandrakis, Panagiotis ; Ntanasis-Stathopoulos, Ioannis ; et al.

In Blood 15 May 2025 145(20):2353-2360
- View full text via DOI
Merkliste

24
Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma: results of the Phase 2 study IZALCO

von Parmar, Gurdeep ; Capra, Marcelo ; Seguro, Fernanda ; et al.

Blood Cancer Journal. 16(1)
- Zum Volltext in PubMed Central
Merkliste

25
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag